Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington

Products derived from Cannabis sativa L. have gained increased interest and popularity. As these products become common amongst the public, the health and potential therapeutic values associated with hemp have become a premier focus of research. While the psychoactive and medicinal properties of Cannabis products have been extensively highlighted in the literature, the antibacterial properties of cannabidiol (CBD) have not been explored in depth. This research serves to examine the antibacterial potential of CBD against Salmonella newington and S. typhimurium. In this study, we observed bacterial response to CBD exposure through biological assays, bacterial kinetics, and fluorescence microscopy. Additionally, comparative studies between CBD and ampicillin were conducted against S. typhimurium and S. newington to determine comparative efficacy. Furthermore, we observed potential resistance development of our Salmonella spp. against CBD treatment.

[1]  Joseph A. Ayariga,et al.  Capsaicin Potently Blocks Salmonella typhimurium Invasion of Vero Cells , 2022, bioRxiv.

[2]  Joseph A. Ayariga,et al.  P22 Phage Shows Promising Antibacterial Activity under Pathophysiological Conditions , 2021, Archives of microbiology & immunology.

[3]  Joseph A. Ayariga,et al.  Ɛ34 Phage Tailspike Protein is Resistant to Trypsin and Inhibits and Salmonella Biofilm Formation , 2021 .

[4]  R. Villafane,et al.  The E34 Phage Tailspike Protein: An in vitro characterization, Structure Prediction, Potential Interaction with S. newington LPS and Cytotoxicity Assessment to Animal Cell Line , 2021, bioRxiv.

[5]  S. Fahad,et al.  Evaluation of hemp (Cannabis sativa L.) as an industrial crop: a review , 2021, Environmental Science and Pollution Research.

[6]  A. Shahbazi,et al.  Extraction of Cannabinoids from Cannabis sativa L. (Hemp)—Review , 2021, Agriculture.

[7]  P. Messi,et al.  Essential Oils: A Natural Weapon against Antibiotic-Resistant Bacteria Responsible for Nosocomial Infections , 2021, Antibiotics.

[8]  J. Gunn,et al.  Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract , 2021, Frontiers in Cellular and Infection Microbiology.

[9]  M. Farré,et al.  UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis. , 2021, Talanta.

[10]  S. Mazzacane,et al.  Bacteriophages as a Potential 360-Degree Pathogen Control Strategy , 2021, Microorganisms.

[11]  J. Pogliano,et al.  The antimicrobial potential of cannabidiol , 2021, Communications Biology.

[12]  S. Carradori,et al.  Metabolomic Profile and Antioxidant/Anti-Inflammatory Effects of Industrial Hemp Water Extract in Fibroblasts, Keratinocytes and Isolated Mouse Skin Specimens , 2021, Antioxidants.

[13]  R. Sprague,et al.  Cannabis Regulatory Confusion and Its Impact on Consumer Adoption , 2020 .

[14]  B. Fiani,et al.  Current application of cannabidiol (CBD) in the management and treatment of neurological disorders , 2020, Neurological Sciences.

[15]  E. Lichtfouse,et al.  Applications of hemp in textiles, paper industry, insulation and building materials, horticulture, animal nutrition, food and beverages, nutraceuticals, cosmetics and hygiene, medicine, agrochemistry, energy production and environment: a review , 2020, Environmental Chemistry Letters.

[16]  Rachit Agarwal,et al.  Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions , 2020, bioRxiv.

[17]  Benjamin J. Whalley,et al.  The proposed mechanisms of action of CBD in epilepsy. , 2020, Epileptic disorders : international epilepsy journal with videotape.

[18]  S. Atalay,et al.  Antioxidative and Anti-Inflammatory Properties of Cannabidiol , 2019, Antioxidants.

[19]  L. Moja,et al.  Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool. , 2019, The Lancet. Infectious diseases.

[20]  R. Laxminarayan,et al.  Antibiotic development — economic, regulatory and societal challenges , 2019, Nature Reviews Microbiology.

[21]  Antibiotic resistance threats in the United States, 2019 , 2019 .

[22]  Jimmy D Bell,et al.  Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles , 2019, Front. Cell. Infect. Microbiol..

[23]  S. Benvenuti,et al.  Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp) , 2019, Molecules.

[24]  Paramita Sarkar,et al.  Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance. , 2019, Trends in microbiology.

[25]  C. White,et al.  A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential , 2019, Journal of clinical pharmacology.

[26]  L. Cardozo-Filho,et al.  Supercritical Extraction Strategies Using CO2 and Ethanol to Obtain Cannabinoid Compounds from Cannabis Hybrid Flowers , 2018, Journal of CO2 Utilization.

[27]  R. Croft,et al.  Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial , 2018, Cannabis and cannabinoid research.

[28]  Joseph Chien,et al.  Contemporary Routes of Cannabis Consumption: A Primer for Clinicians , 2018, The Journal of the American Osteopathic Association.

[29]  Henry C. Lin,et al.  Phage therapy: An alternative to antibiotics in the age of multi-drug resistance , 2017, World journal of gastrointestinal pharmacology and therapeutics.

[30]  R. Pacifici,et al.  Neurological Disorders in Medical Use of Cannabis: An Update. , 2017, CNS & neurological disorders drug targets.

[31]  Zhongzhen Zhao,et al.  Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids? , 2017, Front. Pharmacol..

[32]  D. Demske,et al.  Cannabis in Eurasia: origin of human use and Bronze Age trans-continental connections , 2017, Vegetation History and Archaeobotany.

[33]  T. Karl,et al.  In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease , 2017, Front. Pharmacol..

[34]  A. Djikeng,et al.  Genetic markers associated with resistance to beta-lactam and quinolone antimicrobials in non-typhoidal Salmonella isolates from humans and animals in central Ethiopia , 2017, Antimicrobial Resistance & Infection Control.

[35]  Kim F. Wong,et al.  Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States , 2015, MMWR. Morbidity and mortality weekly report.

[36]  J. Turnidge,et al.  Susceptibility Test Methods: Dilution and Disk Diffusion Methods* , 2015 .

[37]  A. Steven,et al.  Structural engineering of a phage lysin that targets Gram-negative pathogens , 2012, Proceedings of the National Academy of Sciences.

[38]  D. Livermore.  Has the era of untreatable infections arrived? , 2009, The Journal of antimicrobial chemotherapy.

[39]  L. Berti,et al.  Geraniol Restores Antibiotic Activities against Multidrug-Resistant Isolates from Gram-Negative Species , 2009, Antimicrobial Agents and Chemotherapy.

[40]  Michael Stavri,et al.  Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. , 2008, Journal of natural products.

[41]  S. Ricke,et al.  Environmental Dissemination of Foodborne Salmonella in Preharvest Poultry Production: Reservoirs, Critical Factors, and Research Strategies , 2008 .

[42]  A. Zuardi.  History of cannabis as a medicine: a review. , 2006, Revista brasileira de psiquiatria.

[43]  M. Amar.  Cannabinoids in medicine: A review of their therapeutic potential. , 2006 .

[44]  D G White,et al.  The isolation of antibiotic-resistant salmonella from retail ground meats. , 2001, The New England journal of medicine.

[45]  S. Tatini,et al.  Incidence of Salmonella in fish and seafood. , 2000, Journal of food protection.

[46]  S. Kaufmann,et al.  Immune response to infection with Salmonella typhimurium in mice , 2000, Journal of leukocyte biology.

[47]  J. J. Borrego,et al.  Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish. , 1999, The Journal of antimicrobial chemotherapy.

[48]  Hiroshi Nikaido,et al.  Multidrug Efflux Pump AcrAB of Salmonella typhimuriumExcretes Only Those β-Lactam Antibiotics Containing Lipophilic Side Chains , 1998, Journal of bacteriology.

[49]  F. Gannon,et al.  Plaque dot assay. , 1986, Nucleic acids research.

[50]  F. Bryan,et al.  Foodborne Diseases in the United States Associated with Meat and Poultry. , 1980, Journal of food protection.

[51]  M. Katz,et al.  Psychological effects of tetrahydrocannabinol. , 1970, Archives of general psychiatry.

[52]  Thomas A. Koelble,et al.  Bongalong: Marketing Cannabis Products in a Stigmatized Environment , 2018 .

[53]  Ubong Anyi,et al.  Salmonella: a foodborne pathogen , 2011 .

[54]  M. Ben Amar,et al.  Cannabinoids in medicine: A review of their therapeutic potential. , 2006, Journal of ethnopharmacology.

[55]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[56]  B. Klingeren,et al.  Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol , 2004, Antonie van Leeuwenhoek.

[57]  H. Kalant.  Medicinal use of cannabis: history and current status. , 2001, Pain research & management.

[58]  R. N. Takahashi,et al.  Effects of Δ9-Tetrahydrocannabinol and Cannabinol in Man , 1975 .

[59]  R. Musty,et al.  Effects of delta9-tetrahydrocannabinol and cannabinol in man. , 1975, Pharmacology.

[60]  J. H. Warren,et al.  Clinical usefulness of a single disc method for antibiotic sensitivity testing. , 1956, Antibiotics annual.